Ingram Biosciences Private Limited

TAFFIC is a fixed dose combination product (three-drug) containing 50 mg of bictegravir (BIC), 200 mg of emtricitabine (FTC), and 25 mg of tenofovir alafenamide (TAF). 
TAFFIC is a prescription medicine that is used to treat Human Immunodeficiency Virus-1 (HIV-1) in adults and children who weigh at least 25 kg. to replace their current anti-HIV-1 medicines for people whose healthcare provider determines that they meet certain requirements.

CRIZALK (Crizotinib) is an anticancer medicine containing the active substance crizotinib used to treat patients with a type of lung cancer called locally advanced or metastatic (spread outside lungs or to other parts of the body) non-small cell lung cancer (NSCLC), that is anaplastic lymphoma kinase (ALK)-positive as